Search research articles
Contact Us
Filters
Showing results (131-140 of 199) with videos related to
Page
of 20
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2015
ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer
Ramaswamy Govindan, Sumithra J Mandrekar, David E Gerber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 11, 2022
SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer
Umang Swami, Ryon P Graf, Roberto H Nussenzveig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2016
MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression
Mark M Awad, Geoffrey R Oxnard, David M Jackman, et al.
JTO Clinical and Research Reports
|
September 30, 2021
The Genomics of Young Lung Cancer: Comprehensive Tissue Genomic Analysis in Patients Under 40 With Lung Cancer
Barbara J Gitlitz, Silvia Novello, Tiziana Vavalà, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2017
A Phase I, Dose Escalation Study of Oral ASP8273 in Patients with Non-small Cell Lung Cancers with Epidermal Growth Factor Receptor Mutations
Helena A Yu, Alexander Spira, Leora Horn, et al.
JTO Clinical and Research Reports
|
July 25, 2022
Brief Report: Safety and Antitumor Activity of Alectinib Plus Atezolizumab From a Phase 1b Study in Advanced <i>ALK</i>-Positive NSCLC
Dong-Wan Kim, Shirish Gadgeel, Scott N Gettinger, et al.
JCO Precision Oncology
|
December 1, 2022
Response to MEK Inhibitor Therapy in <i>MAP2K1</i> (<i>MEK1</i>) K57N Non-Small-Cell Lung Cancer and Genomic Landscape of <i>MAP2K1</i> Mutations in Non-Small-Cell Lung Cancer
Michael L Cheng, Jessica K Lee, Rachit Kumar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 22, 2014
Prognostic impact of KRAS mutation subtypes in 677 patients with metastatic lung adenocarcinomas
Helena A Yu, Camelia S Sima, Ronglai Shen, et al.
Cancer Research
|
April 2, 2017
Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors
Takayuki Kosaka, Junko Tanizaki, Raymond M Paranal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2021
Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA
Xiaoji Chen, Zhao Dong, Earl Hubbell, et al.
Page
of 20
Search research articles
Search
Showing results (131-140 of 199) with videos related to
Sort By:
Page
of 20
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2015
ALCHEMIST Trials: A Golden Opportunity to Transform Outcomes in Early-Stage Non-Small Cell Lung Cancer
Ramaswamy Govindan, Sumithra J Mandrekar, David E Gerber, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 11, 2022
SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer
Umang Swami, Ryon P Graf, Roberto H Nussenzveig, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 6, 2016
MET Exon 14 Mutations in Non-Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression
Mark M Awad, Geoffrey R Oxnard, David M Jackman, et al.
JTO Clinical and Research Reports
|
September 30, 2021
The Genomics of Young Lung Cancer: Comprehensive Tissue Genomic Analysis in Patients Under 40 With Lung Cancer
Barbara J Gitlitz, Silvia Novello, Tiziana Vavalà, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2017
A Phase I, Dose Escalation Study of Oral ASP8273 in Patients with Non-small Cell Lung Cancers with Epidermal Growth Factor Receptor Mutations
Helena A Yu, Alexander Spira, Leora Horn, et al.
JTO Clinical and Research Reports
|
July 25, 2022
Brief Report: Safety and Antitumor Activity of Alectinib Plus Atezolizumab From a Phase 1b Study in Advanced <i>ALK</i>-Positive NSCLC
Dong-Wan Kim, Shirish Gadgeel, Scott N Gettinger, et al.
JCO Precision Oncology
|
December 1, 2022
Response to MEK Inhibitor Therapy in <i>MAP2K1</i> (<i>MEK1</i>) K57N Non-Small-Cell Lung Cancer and Genomic Landscape of <i>MAP2K1</i> Mutations in Non-Small-Cell Lung Cancer
Michael L Cheng, Jessica K Lee, Rachit Kumar, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
November 22, 2014
Prognostic impact of KRAS mutation subtypes in 677 patients with metastatic lung adenocarcinomas
Helena A Yu, Camelia S Sima, Ronglai Shen, et al.
Cancer Research
|
April 2, 2017
Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors
Takayuki Kosaka, Junko Tanizaki, Raymond M Paranal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2021
Prognostic Significance of Blood-Based Multi-cancer Detection in Plasma Cell-Free DNA
Xiaoji Chen, Zhao Dong, Earl Hubbell, et al.
Page
of 20